Target therapy for hepatocellular carcinoma: is sorafenib for everybody?
- PMID: 19564813
- DOI: 10.1097/MCG.0b013e31819eb9a6
Target therapy for hepatocellular carcinoma: is sorafenib for everybody?
Comment on
-
Safety and efficacy of sorafenib in patients with advanced hepatocellular carcinoma in consideration of concomitant stage of liver cirrhosis.J Clin Gastroenterol. 2009 May-Jun;43(5):489-95. doi: 10.1097/MCG.0b013e31818ddfc6. J Clin Gastroenterol. 2009. PMID: 19247201
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
